The University of Texas Health Science Center at Tyler

• Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

  Collaborator, Phase 2, Recruiting, 105 people, 15 Feb 2023

• NCT04658420

  Phase 2, Status unknown, 200 people, 8 Dec 2020

Sources: clinicaltrials.gov